213 related articles for article (PubMed ID: 35577938)
1. Recommendations for whole genome sequencing in diagnostics for rare diseases.
Souche E; Beltran S; Brosens E; Belmont JW; Fossum M; Riess O; Gilissen C; Ardeshirdavani A; Houge G; van Gijn M; Clayton-Smith J; Synofzik M; de Leeuw N; Deans ZC; Dincer Y; Eck SH; van der Crabben S; Balasubramanian M; Graessner H; Sturm M; Firth H; Ferlini A; Nabbout R; De Baere E; Liehr T; Macek M; Matthijs G; Scheffer H; Bauer P; Yntema HG; Weiss MM
Eur J Hum Genet; 2022 Sep; 30(9):1017-1021. PubMed ID: 35577938
[TBL] [Abstract][Full Text] [Related]
2. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants.
Belkadi A; Bolze A; Itan Y; Cobat A; Vincent QB; Antipenko A; Shang L; Boisson B; Casanova JL; Abel L
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5473-8. PubMed ID: 25827230
[TBL] [Abstract][Full Text] [Related]
3. Validated WGS and WES protocols proved saliva-derived gDNA as an equivalent to blood-derived gDNA for clinical and population genomic analyses.
Kvapilova K; Misenko P; Radvanszky J; Brzon O; Budis J; Gazdarica J; Pos O; Korabecna M; Kasny M; Szemes T; Kvapil P; Paces J; Kozmik Z
BMC Genomics; 2024 Feb; 25(1):187. PubMed ID: 38365587
[TBL] [Abstract][Full Text] [Related]
4. Integration of whole genome sequencing into a healthcare setting: high diagnostic rates across multiple clinical entities in 3219 rare disease patients.
Stranneheim H; Lagerstedt-Robinson K; Magnusson M; Kvarnung M; Nilsson D; Lesko N; Engvall M; Anderlid BM; Arnell H; Johansson CB; Barbaro M; Björck E; Bruhn H; Eisfeldt J; Freyer C; Grigelioniene G; Gustavsson P; Hammarsjö A; Hellström-Pigg M; Iwarsson E; Jemt A; Laaksonen M; Enoksson SL; Malmgren H; Naess K; Nordenskjöld M; Oscarson M; Pettersson M; Rasi C; Rosenbaum A; Sahlin E; Sardh E; Stödberg T; Tesi B; Tham E; Thonberg H; Töhönen V; von Döbeln U; Vassiliou D; Vonlanthen S; Wikström AC; Wincent J; Winqvist O; Wredenberg A; Ygberg S; Zetterström RH; Marits P; Soller MJ; Nordgren A; Wirta V; Lindstrand A; Wedell A
Genome Med; 2021 Mar; 13(1):40. PubMed ID: 33726816
[TBL] [Abstract][Full Text] [Related]
5. Archived neonatal dried blood spot samples can be used for accurate whole genome and exome-targeted next-generation sequencing.
Hollegaard MV; Grauholm J; Nielsen R; Grove J; Mandrup S; Hougaard DM
Mol Genet Metab; 2013; 110(1-2):65-72. PubMed ID: 23830478
[TBL] [Abstract][Full Text] [Related]
6. A practical method to detect SNVs and indels from whole genome and exome sequencing data.
Shigemizu D; Fujimoto A; Akiyama S; Abe T; Nakano K; Boroevich KA; Yamamoto Y; Furuta M; Kubo M; Nakagawa H; Tsunoda T
Sci Rep; 2013; 3():2161. PubMed ID: 23831772
[TBL] [Abstract][Full Text] [Related]
7. Reporting results from whole-genome and whole-exome sequencing in clinical practice: a proposal for Canada?
Zawati MH; Parry D; Thorogood A; Nguyen MT; Boycott KM; Rosenblatt D; Knoppers BM
J Med Genet; 2014 Jan; 51(1):68-70. PubMed ID: 24078715
[TBL] [Abstract][Full Text] [Related]
8. From cytogenetics to cytogenomics: whole-genome sequencing as a first-line test comprehensively captures the diverse spectrum of disease-causing genetic variation underlying intellectual disability.
Lindstrand A; Eisfeldt J; Pettersson M; Carvalho CMB; Kvarnung M; Grigelioniene G; Anderlid BM; Bjerin O; Gustavsson P; Hammarsjö A; Georgii-Hemming P; Iwarsson E; Johansson-Soller M; Lagerstedt-Robinson K; Lieden A; Magnusson M; Martin M; Malmgren H; Nordenskjöld M; Norling A; Sahlin E; Stranneheim H; Tham E; Wincent J; Ygberg S; Wedell A; Wirta V; Nordgren A; Lundin J; Nilsson D
Genome Med; 2019 Nov; 11(1):68. PubMed ID: 31694722
[TBL] [Abstract][Full Text] [Related]
9. Critical points for an accurate human genome analysis.
White SJ; Laros JFJ; Bakker E; Cambon-Thomsen A; Eden M; Leonard S; Lochmüller H; Matthijs G; Mattocks C; Patton S; Payne K; Scheffer H; Souche E; Thomassen E; Thompson R; Traeger-Synodinos J; Van Vooren S; Janssen B; den Dunnen JT
Hum Mutat; 2017 Aug; 38(8):912-921. PubMed ID: 28471515
[TBL] [Abstract][Full Text] [Related]
10. Massively Parallel Sequencing for Rare Genetic Disorders: Potential and Pitfalls.
McInerney-Leo AM; Duncan EL
Front Endocrinol (Lausanne); 2020; 11():628946. PubMed ID: 33679611
[TBL] [Abstract][Full Text] [Related]
11. Analytical and Clinical Validation of a Target-Enhanced Whole Genome Sequencing-Based Comprehensive Genomic Profiling Test.
Ferguson S; Sriram S; Wallace JK; Lee J; Kim JA; Lee Y; Oh BB; Lee WC; Lee S; Connolly-Strong E
Cancer Invest; 2024 May; 42(5):390-399. PubMed ID: 38773925
[TBL] [Abstract][Full Text] [Related]
12. Analytical validation of whole exome and whole genome sequencing for clinical applications.
Linderman MD; Brandt T; Edelmann L; Jabado O; Kasai Y; Kornreich R; Mahajan M; Shah H; Kasarskis A; Schadt EE
BMC Med Genomics; 2014 Apr; 7():20. PubMed ID: 24758382
[TBL] [Abstract][Full Text] [Related]
13. Inconsistency and features of single nucleotide variants detected in whole exome sequencing versus transcriptome sequencing: A case study in lung cancer.
O'Brien TD; Jia P; Xia J; Saxena U; Jin H; Vuong H; Kim P; Wang Q; Aryee MJ; Mino-Kenudson M; Engelman JA; Le LP; Iafrate AJ; Heist RS; Pao W; Zhao Z
Methods; 2015 Jul; 83():118-27. PubMed ID: 25913717
[TBL] [Abstract][Full Text] [Related]
14. Added Value of Reanalysis of Whole Exome- and Whole Genome Sequencing Data From Patients Suspected of Primary Immune Deficiency Using an Extended Gene Panel and Structural Variation Calling.
Mørup SB; Nazaryan-Petersen L; Gabrielaite M; Reekie J; Marquart HV; Hartling HJ; Marvig RL; Katzenstein TL; Masmas TN; Lundgren J; Murray DD; Helleberg M; Borgwardt L
Front Immunol; 2022; 13():906328. PubMed ID: 35874679
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of single nucleotide variant detection performance using three massively parallel sequencing methods.
Trudsø LC; Andersen JD; Jacobsen SB; Christiansen SL; Congost-Teixidor C; Kampmann ML; Morling N
PLoS One; 2020; 15(9):e0239850. PubMed ID: 32986766
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic yield of exome and genome sequencing after non-diagnostic multi-gene panels in patients with single-system diseases.
Wilke MVMB; Klee EW; Dhamija R; Fervenza FC; Thomas B; Leung N; Hogan MC; Hager MM; Kolbert KJ; Kemppainen JL; Loftus EC; Leitzen KM; Vitek CR; McAllister T; Lazaridis KN; Pinto E Vairo F
Orphanet J Rare Dis; 2024 May; 19(1):216. PubMed ID: 38790019
[TBL] [Abstract][Full Text] [Related]
17. Toward Clinical Implementation of Next-Generation Sequencing-Based Genetic Testing in Rare Diseases: Where Are We?
Liu Z; Zhu L; Roberts R; Tong W
Trends Genet; 2019 Nov; 35(11):852-867. PubMed ID: 31623871
[TBL] [Abstract][Full Text] [Related]
18. The Use of Next-Generation Sequencing in Pharmacogenomics.
Enko D; Michaelis S; Schneider C; Schaflinger E; Baranyi A; Schnedl WJ; Muller DJ
Clin Lab; 2023 Aug; 69(8):. PubMed ID: 37560847
[TBL] [Abstract][Full Text] [Related]
19. High-coverage whole-genome sequencing of the expanded 1000 Genomes Project cohort including 602 trios.
Byrska-Bishop M; Evani US; Zhao X; Basile AO; Abel HJ; Regier AA; Corvelo A; Clarke WE; Musunuri R; Nagulapalli K; Fairley S; Runnels A; Winterkorn L; Lowy E; ; Paul Flicek ; Germer S; Brand H; Hall IM; Talkowski ME; Narzisi G; Zody MC
Cell; 2022 Sep; 185(18):3426-3440.e19. PubMed ID: 36055201
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of Clinical Whole-Exome and Whole-Genome Sequencing for Detection of Germline Variants in Inherited Disease.
Hegde M; Santani A; Mao R; Ferreira-Gonzalez A; Weck KE; Voelkerding KV
Arch Pathol Lab Med; 2017 Jun; 141(6):798-805. PubMed ID: 28362156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
